In HCC, there is a heterogeneous enhancement of several amino acid transporters, including SLC6A14, SLC38A1, and importantly SLC1A5 and SLC7A6, with a consistent decrease in the expression of SLC38A3. Here, SLC1A5 is linked to hepatocellular carcinoma.